ARIANNA YOUELL: Open Payments
NPI 1427591510 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 52 payments from 12 companies in 2025. Trend: 2023 $576 · 2024 $1,975 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 16 | $272 |
| ABBVIE INC. | 15 | $259 |
| Janssen Biotech, Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $90 |
| Ardelyx, Inc. | 3 | $74 |
| Gilead Sciences, Inc. | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Celltrion USA Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $28 |
Products named: VOQUEZNA, LINZESS, TREMFYA, IBSRELA, RINVOQ, ENTYVIO, REZDIFFRA, XIFAXAN.
Industry payments across CT — which companies pay providers there.
